Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment

Overview of attention for article published in Experimental Hematology & Oncology, November 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#44 of 317)
Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 69 Dimensions

Readers on

mendeley: 157 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

METHODS OF USING A BISPECIFIC ANTIGEN-BINDING CONSTRUCT TARGETING HER2 FOR THE TREATMENT…

Application EP-3976098-A4

European Patent Office

COMBINATION THERAPIES FOR TREATMENT OF HER2 CANCER

Application WO-2022125483-A1

World Intellectual Property Organisation (WIPO)

EFFICACIOUS DOSE FOR HER2 BISPECIFIC ANTIBODY

Application WO-2021190636-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.